The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide.

[1]  H. Traoré,et al.  [Study of antigen HBs and antivirus antibodies of hepatitis C during hepatopathies in Mali]. , 2004, Bulletin de la Societe de pathologie exotique.

[2]  S. Francque,et al.  Viral hepatitis and hepatocellular carcinoma , 2005, World journal of surgical oncology.

[3]  G. M. Mabrouk.  Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma. , 1997, Disease markers.

[4]  R. Mondragón-Sánchez,et al.  Hepatocellular carcinoma and hepatitis C in Mexico. , 2005, Hepato-gastroenterology.

[5]  Mabrouk Gm.  Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma , 1997 .

[6]  C. Sempos,et al.  The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. , 2003, Addiction.

[7]  G. Strickland,et al.  High prevalence of hepatitis C in Egyptian patients with chronic liver disease. , 1995, Gut.

[8]  Ding-Shinn Chen,et al.  Global control of hepatitis B virus infection. , 2002, The Lancet. Infectious diseases.

[9]  H. Ishibashi,et al.  Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma. , 2003, Hepato-gastroenterology.

[10]  H. Akil,et al.  Hepatitis B and C virus infection in Ujung Pandang, Indonesia , 1991, Gastroenterologia Japonica.

[11]  J. Primo,et al.  Incidence and epidemiological factors of hepatocellular carcinoma in Valencia during the year 2000. , 2003, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[12]  P. Tangkijvanich,et al.  Association of hepatitis viruses with hepatocellular carcinoma in Thailand , 1999, Journal of Gastroenterology.

[13]  T. Ishikawa,et al.  High prevalence of hepatitis C in patients with thalassemia and patients with liver diseases in Myanmar (Burma). , 2000, Acta medica Okayama.

[14]  Wan Ariffin Bin Abdullah.  Singapore Med J , 1993 .

[15]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[16]  W Ray Kim,et al.  Global epidemiology and burden of hepatitis C. , 2002, Microbes and infection.

[17]  E. Hajiani,et al.  Risk factors for hepatocellular carcinoma in Southern Iran. , 2005, Saudi medical journal.

[18]  G. Jamjoom,et al.  Serodiagnosis of hepatitis C in acute and chronic liver disease in southwestern Saudi Arabia. , 1992, The Journal of tropical medicine and hygiene.

[19]  R. Bruni,et al.  Hepatitis C virus infection in chronic liver disease in Somalia. , 1993, The American journal of tropical medicine and hygiene.

[20]  Y. Ko,et al.  Habitual Betel Quid Chewing as a Risk Factor for Cirrhosis: A Case-Control Study , 2003, Medicine.

[21]  Manal M. Hassan,et al.  The Role of Hepatitis C in Hepatocellular Carcinoma: A Case Control Study Among Egyptian Patients , 2001, Journal of clinical gastroenterology.

[22]  E. BenítezRodríguez,et al.  Risk factors for hepatocellular carcinoma in patients with liver cirrhosis. , 2000 .

[23]  H. Triki.  [Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia]. , 1994, Archives de l'Institut Pasteur de Tunis.

[24]  Khazanov Ai.  Current problems of viral and alcohol diseases of the liver , 2002 .

[25]  Zakirov Ig.  Liver cirrhosis and liver cancer associated with viral hepatitis B and C in republic of Tatarstan , 2003 .

[26]  M. Brook,et al.  Treatment of hepatitis. , 1988, The Journal of hospital infection.

[27]  S. Hadler,et al.  Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group , 2004 .

[28]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[29]  Y. Shiratori,et al.  Clinical features of patients with HCC who are negative for both HBV and HCV markers. , 2003, Hepato-gastroenterology.

[30]  Yves Renaudineau,et al.  [Hepatitis C virus and chronic hepatopathies in Dakar: case-control study]. , 2000, Medecine tropicale : revue du Corps de sante colonial.

[31]  S. Porru,et al.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. , 2002, American journal of epidemiology.

[32]  Ming‐Ying Liu,et al.  Hepatitis C virus infections and genotypes in China. , 2002, Hepatobiliary & pancreatic diseases international : HBPD INT.

[33]  C. Yurdaydın,et al.  Risk Factors for Hepatocellular Carcinoma in Turkey , 2001, Digestive Diseases and Sciences.

[34]  P Boffetta,et al.  A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.

[35]  Mary Ellen Kitler,et al.  Global burden of disease (GBD) for hepatitis C , 2004 .

[36]  A. Simjee,et al.  Hepatitis C virus infection in chronic liver disease in Natal. , 1996, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[37]  P. Rathi,et al.  Hepatitis B subtypes and hepatitis C genotypes in cirrhosis in western India: results of a pilot study. , 1999, The Journal of the Association of Physicians of India.

[38]  T. Hussain,et al.  Hepatitis B and C single and co-infection in chronic liver disease and their effect on the disease pattern. , 2003, JPMA. The Journal of the Pakistan Medical Association.

[39]  K. Hyams,et al.  Chronic liver disease in Peru: Role of viral hepatitis , 1994, Journal of medical virology.

[40]  Sokolov Mi.  Epidemiology and prevention of hepatitis , 1975 .

[41]  M. Alter.  Epidemiology and Prevention of Hepatitis B , 2003, Seminars in liver disease.

[42]  Bao-en Wang,et al.  Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: Survey of 414 patients from four countries , 2002, Journal of medical virology.

[43]  A. Tamori,et al.  High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan. , 1999, Hepato-gastroenterology.

[44]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[45]  K. Alam,et al.  Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects. , 1995, The Journal of tropical medicine and hygiene.

[46]  T. Nishizawa,et al.  High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia , 2005, Journal of medical virology.

[47]  T. O'Brien,et al.  Hepatocellular Carcinoma: Paradigm of Preventive Oncology , 2004, Cancer journal.

[48]  S. Sarin,et al.  Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations , 2001, Journal of gastroenterology and hepatology.

[49]  Francesco Donato,et al.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.

[50]  H. Blum,et al.  Pathogenesis of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.

[51]  J. Clemens,et al.  Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. , 2001, The American journal of tropical medicine and hygiene.

[52]  E. Ruiz,et al.  [HEPATITIS B AND C VIRUS INFECTION AS RISK FACTORS FORHEPATOCARCINOMA IN PERU: CASE AND CONTROL STUDY] , 1998, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[53]  H. Okamoto,et al.  Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease or on maintenance hemodialysis in Indonesia , 1994, Journal of medical virology.

[54]  Y. Wakamatsu,et al.  Imaging Liver Development/Remodeling in the See-Through Medaka Fish , 2004, Comparative hepatology.

[55]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  Colin W Shepard,et al.  Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.

[57]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[58]  E. Benítez Rodríguez,et al.  Risk factors for hepatocellular carcinoma in patients with liver cirrhosis. , 2000, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[59]  S. Demachki,et al.  [Hepatitis B and C virus infection and the hepatocellular carcinoma in the East Amazon, Brazil]. , 2004, Revista da Sociedade Brasileira de Medicina Tropical.

[60]  G. Odaibo,et al.  Hepatitis B and C virus and hepatocellular carcinoma. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[61]  Hiroshi Suzuki.  Viral Hepatitis in Japan , 1994 .

[62]  E. Libon,et al.  Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients. , 2000, Acta gastro-enterologica Belgica.

[63]  N. Khokhar.  Spectrum of chronic liver disease in a tertiary care hospital. , 2002, JPMA. The Journal of the Pakistan Medical Association.

[64]  H. J. Kim,et al.  The Change of the Etiology, Complications and Cause of Death of the Liver Cirrhosis in 1990s , 2000 .

[65]  S. Iino.  [Epidemiology and prevention of hepatitis A]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[66]  H B el-Serag.  Epidemiology of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[67]  Thomas K. Hazlet,et al.  Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.

[68]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[69]  S. Mcligeyo,et al.  The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. , 1995, East African medical journal.

[70]  A. Bisceglie,et al.  Risk Factors for Hepatocellular Carcinoma in Patients with Cirrhosis , 2004, Digestive Diseases and Sciences.

[71]  G. Armstrong.  Commentary: Modelling the epidemiology of hepatitis C and its complications. , 2003, International journal of epidemiology.

[72]  A. Chlumská,et al.  Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic , 1997, Infection.

[73]  M. Manns,et al.  Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. , 2000, Liver.

[74]  E. Sagnelli,et al.  Trends of aetiological factors of hepatocellular carcinoma in Italy. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[75]  J. Hakim,et al.  Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[76]  Shiyuan Liu,et al.  A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.

[77]  M. Alter,et al.  Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.

[78]  P. Coursaget,et al.  Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia. , 1992, Pathologie-biologie.

[79]  G. Gores,et al.  Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. , 2003 .

[80]  E. Sagnelli,et al.  The importance of HCV on the burden of chronic liver disease in Italy: A multicenter prevalence study of 9,997 cases , 2005, Journal of medical virology.

[81]  C. Hellerbrand,et al.  Hepatocellular Carcinoma in Southern Germany: Epidemiological and Clinicopathological Characteristics and Risk Factors , 2002, Digestive Diseases.

[82]  R. Aggarwal,et al.  Occult hepatitis B virus infection as a cause of cirrhosis of liver in a region with intermediate endemicity. , 2003, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[83]  C. S. J. Stránsky M. D.,et al.  Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic , 2005, Infection.

[84]  Jamjoom Ga,et al.  Serodiagnosis of hepatitis C in acute and chronic liver disease in southwestern Saudi Arabia. , 1992 .

[85]  A. D. Di Bisceglie,et al.  Clinical presentation and natural course of hepatocellular carcinoma. , 2005, European journal of gastroenterology & hepatology.

[86]  A. Khazanov.  [Current problems of viral and alcohol diseases of the liver]. , 2002, Klinicheskaia meditsina.

[87]  Sheng-Nan Lu,et al.  Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection , 1999, Cancer.

[88]  G. Gores,et al.  Hepatitis C–related hepatocellular carcinoma in the United States: influence of ethnic status , 2003, American Journal of Gastroenterology.

[89]  Santhanam,et al.  Association of hepatitis C virus & hepatitis B virus in chronic liver disease. , 1998, The Indian journal of medical research.

[90]  P. Tangkijvanich,et al.  Hepatitis viruses and chronic liver disease. , 1999, The Southeast Asian journal of tropical medicine and public health.

[91]  D. Trichopoulos,et al.  Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays , 2000, Cancer Causes & Control.

[92]  G. Corrao,et al.  Interaction between alcohol consumption and positivity for antibodies to hepatitis C virus on the risk of liver cirrhosis: A case-control study , 1992, European Journal of Epidemiology.

[93]  E. C. B. M. Miranda,et al.  Infecções pelos vírus das hepatites B e C e o carcinoma hepatocelular na Amazônia oriental , 2004 .

[94]  K. Mitamura,et al.  Risk factors for infections in cirrhotic patients with and without hepatocellular carcinoma , 2002, Journal of Gastroenterology.

[95]  Manal M. Hassan,et al.  Rising Prevalence of Hepatitis C Virus Infection Among Patients Recently Diagnosed With Hepatocellular Carcinoma in the United States , 2002, Journal of clinical gastroenterology.

[96]  H. Okamoto,et al.  Hepatitis B virus subtypes and hepatitis C virus genotypes in patients with chronic liver disease in Nepal , 1994, Hepatology.

[97]  J. Goedert,et al.  The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa , 2004, Hepatology.

[98]  S. Dong,et al.  Clinical features of HBsAg‐negative but anti‐HBc‐positive hepatocellular carcinoma in a hepatitis B virus endemic area , 2005, Journal of gastroenterology and hepatology.

[99]  E. Sagnelli,et al.  Characteristics of liver cirrhosis in Italy: results from a multicenter national study. , 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[100]  H. Thomas,et al.  Hepatitis B virus markers, hepatitis D virus antigen and hepatitis C virus antibodies in Nigerian patients with chronic liver disease. , 1995, East African medical journal.

[101]  P. van’t Veer,et al.  The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[102]  H. Okamoto,et al.  Hepatitis C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand , 1994, Journal of medical virology.

[103]  N. Chalasani,et al.  Screening for hepatocellular carcinoma in patients with advanced cirrhosis , 1999, American Journal of Gastroenterology.

[104]  O. Ozyılkan,et al.  Hepatitis B virus and hepatitis C virus infections in Turkish patients with hepatocellular carcinoma. , 1996, The American journal of gastroenterology.

[105]  S. Shariq,et al.  Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia , 1992, Journal of gastroenterology and hepatology.

[106]  K. Hyams.  Chronic liver disease among U.S. military patients: the role of hepatitis C and G virus infection. , 2000, Military medicine.

[107]  A. Lok.  The maze of treatments for hepatitis B. , 2005, The New England journal of medicine.

[108]  M. Uribe,et al.  Etiology of liver cirrhosis in Mexico. , 2004, Annals of hepatology.

[109]  Lu-Yu Hwang,et al.  Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus , 2002, Hepatology.

[110]  B. Hansson,et al.  Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[111]  E. A. Ayoola,et al.  Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection , 2004, Journal of gastroenterology and hepatology.

[112]  T. Wright,et al.  The epidemiology and prevention of hepatocellular carcinoma. , 2001, Seminars in oncology.

[113]  E. Delaporte,et al.  [HBs Ag and antibodies to hepatitis C virus in complicated chronic liver disease in Gabon. A case control study]. , 2002, Gastroenterologie clinique et biologique.

[114]  D. Lavanchy,et al.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures , 2004, Journal of viral hepatitis.

[115]  J. Guàrdia,et al.  Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan , 1998, European Journal of Epidemiology.

[116]  H. Fukui,et al.  Hepatitis C virus infection in patients with chronic liver diseases , 1991, Gastroenterologia Japonica.

[117]  F. Kayaselçuk,et al.  Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. , 2003, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[118]  L. Khin,et al.  Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore. , 1996, Singapore medical journal.

[119]  M. Buti,et al.  Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C. , 2005, Journal of hepatology.

[120]  M. Alter,et al.  The coming wave of HCV-related liver disease: dilemmas and challenges. , 2006, Journal of hepatology.

[121]  T. Frieden,et al.  Chronic liver disease in central harlem: The role of alcohol and viral hepatitis , 1999, Hepatology.

[122]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.

[123]  M. Szklo,et al.  The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: a case-control study in Albania , 1998, Epidemiology and Infection.

[124]  C. Gonçalves,et al.  Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995). , 1997, Revista do Instituto de Medicina Tropical de Sao Paulo.

[125]  I. G. Zakirov.  [Liver cirrhosis and liver cancer associated with viral hepatitis B and C in republic of Tatarstan]. , 2003, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.